Genomics is advancing precision medicine and improving patient health and wellness. We are at a place now with NGS-based comprehensive genomic profiling where one biopsy, one test, and one report can lead to improved outcomes for cancer patients.
Doctors are using genomics to help identify the cause of undiagnosed rare diseases, helping families avoid years of hospital visits and unnecessary tests. Additionally, genomics is driving the field of pharmacogenomics, potentially leading to better outcomes for both individuals and healthcare providers through improved medication safety and efficacy and lowered medical costs.
Genomics has many benefits in precision medicine. Next-generation sequencing (NGS) can sequence multiple genes at once, identify disease-associated variants to help match patients to therapies or assess disease risk, and help target therapies and reduce overall care costs.
Genomics-powered precision health with NGS also offers the highest likelihood of rare disease diagnosis 9,10. Genomics in precision medicine is becoming a mainstay in clinical labs so it’s no longer just a research tool, and the cost has dropped dramatically. It’s time to consider how NGS precision medicine can support your institution in providing better patient care.
The field of pharmacogenomics can lead to better outcomes for both individuals and healthcare providers through improved medication safety and efficacy and lowered medical costs.